Paper Details

  1. Home
  2. Paper Details

Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.

Author: , BarKatharine J, BarnabasRuanne V, BarouchDan H, BaumAlina, BraunsteinNed, BurwenDale R, ChanKuo-Chen, CohenMyron S, DavisJohn D, DiCioccioA Thomas, Forleo-NetoEduardo, HamiltonJennifer D, HeirmanIngeborg, HermanGary, HooperAndrea T, HouPeijie, HurtChristopher B, IsaFlonza, KimYunji, KowalBari, KrainsonJames, KyratsousChristos A, LipsichLeah, MahmoodAdnan, MarovichMary A, MohseniRizwana, MusserBret J, O'BrienMeagan P, Perez-PerezRichard, PurcellLisa A, RameshDivya, SarkarNeena, StahlNeil, TurnerKenneth C, WeinreichDavid M, YancopoulosGeorge D

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.

Overview

This study explores the potential of a combination of monoclonal antibodies, casirivimab and imdevimab, to prevent COVID-19 infection in people who have been exposed to the virus in a household setting.
Paper Details　
Original Abstract of the Article :
REGEN-COV (previously known as REGN-COV2), a combination of the monoclonal antibodies casirivimab and imdevimab, has been shown to markedly reduce the risk of hospitalization or death among high-risk persons with coronavirus disease 2019 (Covid-19). Whether subcutaneous REGEN-COV prevents severe acu...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362593/

データ提供：米国国立医学図書館（NLM）

REGEN-COV: A New Weapon in the Fight Against COVID-19

The COVID-19 pandemic has presented a monumental challenge for the world, prompting an urgent search for effective treatments and preventive measures. This study, like a frontline medical team battling a pandemic, investigates the potential of REGEN-COV, a combination of monoclonal antibodies, to prevent severe COVID-19. The researchers, like skilled scientists working tirelessly in their laboratories, are exploring the ability of REGEN-COV to protect individuals from the worst effects of COVID-19. This study offers a glimmer of hope in the fight against this global health crisis.

REGEN-COV: A Potential Protective Shield

The study explores the potential of REGEN-COV to prevent severe COVID-19, especially for those at high risk due to household exposure. This is like building a protective barrier against the harsh desert winds, offering a layer of defense against the virus.

Fighting COVID-19: A Multifaceted Approach

This research underscores the importance of developing multiple strategies to combat the COVID-19 pandemic. The exploration of REGEN-COV is a testament to the ongoing efforts to find effective treatments and preventive measures.

Dr.Camel's Conclusion

This study offers a promising exploration of REGEN-COV as a potential preventive measure for COVID-19. The desert of the pandemic is vast and challenging, but with continued research and innovation, we can find new ways to protect ourselves and our communities from this devastating virus.

Date :
  1. Date Completed 2021-10-12
  2. Date Revised 2023-10-19
Further Info :

Pubmed ID

34347950

DOI: Digital Object Identifier

PMC8362593

Related Literature

Article Analysis
・Effects of casirivimab and imdevimab injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.